SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,000 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $97,914,000 | +1.9% | 2,053,991 | -10.2% | 5.33% | -9.9% |
| Q2 2020 | $96,049,000 | +28.5% | 2,286,891 | -17.4% | 5.92% | -15.0% |
| Q1 2020 | $74,726,000 | -36.9% | 2,767,630 | -10.1% | 6.96% | -22.5% |
| Q4 2019 | $118,517,000 | +92.2% | 3,079,155 | +8.3% | 8.99% | +38.7% |
| Q3 2019 | $61,661,000 | – | 2,844,145 | – | 6.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |